{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:46:35Z","timestamp":1783766795696,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","geriatriconcology.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jgo.2024.102184","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T12:59:51Z","timestamp":1736341191000},"page":"102184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Adjuvant taxane-based chemotherapy treatment in older patients with early breast cancer: A pooled analysis of five phase III trials from the Hellenic Oncology Research Group"],"prefix":"10.1016","volume":"16","author":[{"given":"Oraianthi","family":"Fiste","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambros","family":"Vamvakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Katsaounis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Vardakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Kallianteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Georgoulias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Karampeazis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jgo.2024.102184_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jgo.2024.102184_bb0010","series-title":"SEER Cancer Statistics Review, 1975\u20132011","author":"Howlader","year":"2014"},{"issue":"3","key":"10.1016\/j.jgo.2024.102184_bb0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"9814","key":"10.1016\/j.jgo.2024.102184_bb0020","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","article-title":"Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials","volume":"379","author":"Peto","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jgo.2024.102184_bb0025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.6004\/jnccn.2003.0017","article-title":"Decision-making for patients with resectable breast cancer: individualized decisions for and by patients and their physicians","volume":"1","author":"Loprinzi","year":"2003","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.jgo.2024.102184_bb0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12916-015-0439-8","article-title":"Progress in adjuvant chemotherapy for breast cancer: an overview","volume":"13","author":"Anampa","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.jgo.2024.102184_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.940239","article-title":"A systemic review of taxanes and their side effects in metastatic breast cancer","volume":"12","author":"Lai","year":"2022","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.jgo.2024.102184_bb0040","article-title":"Taxanes for adjuvant treatment of early breast cancer","volume":"9","author":"Willson","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"35","key":"10.1016\/j.jgo.2024.102184_bb0045","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1200\/JCO.2011.35.8408","article-title":"Improvement in breast cancer outcomes over time: are older women missing out?","volume":"29","author":"Smith","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2024.102184_bb0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10549-009-0468-0","article-title":"FEC versus sequential docetaxel followed by epirubicin\/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)","volume":"119","author":"Polyzos","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.jgo.2024.102184_bb0055","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10549-014-3202-5","article-title":"Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: a multicenter randomized study of the Hellenic Oncology Research Group (HORG)","volume":"148","author":"Saloustros","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10.1016\/j.jgo.2024.102184_bb0060","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/annonc\/mdv213","article-title":"Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)","volume":"26","author":"Mavroudis","year":"2015","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.jgo.2024.102184_bb0065","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/annonc\/mdw274","volume":"27","author":"Mavroudis","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2024.102184_bb0070","author":"Mavroudis","year":"2015","journal-title":"SABCS"},{"issue":"7","key":"10.1016\/j.jgo.2024.102184_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jgo.2024.102184_bb0085","series-title":"WHO | Definition of an Older or Elderly Person","year":"2024"},{"issue":"24","key":"10.1016\/j.jgo.2024.102184_bb0090","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","article-title":"International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer","volume":"32","author":"Wildiers","year":"2014","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.jgo.2024.102184_bb0095","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1200\/JCO.2006.09.2759","article-title":"Djulbegovic B; National Cancer Institute. Treatment tolerance and efficacy in geriatric oncology: a systematic review of phase III randomized trials conducted by five National Cancer Institute-sponsored cooperative groups","volume":"25","author":"Kumar","year":"2007","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.jgo.2024.102184_bb0100","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1200\/JCO.2003.02.046","article-title":"Undertreatment strongly decreases prognosis of breast cancer in elderly women","volume":"21","author":"Bouchardy","year":"2003","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2024.102184_bb0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.critrevonc.2004.04.002","article-title":"Information needs and decision-making processes in older cancer patients","volume":"51","author":"Pinquart","year":"2004","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.jgo.2024.102184_bb0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pec.2007.03.025","article-title":"Older people\u2019s preferences for involvement in their own care: a qualitative study in primary health care in 11 European countries","volume":"68","author":"Bastiaens","year":"2007","journal-title":"Patient Educ Couns"},{"issue":"27","key":"10.1016\/j.jgo.2024.102184_bb0115","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1200\/JCO.2006.06.3065","article-title":"Breast cancer treatment of older women in integrated health care settings","volume":"24","author":"Enger","year":"2006","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jgo.2024.102184_bb0120","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1016\/S1470-2045(11)70383-7","article-title":"Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)","volume":"13","author":"Biganzoli","year":"2012","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.jgo.2024.102184_bb0125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-120-2-199401150-00002","article-title":"The effect of comorbidity on 3-year survival of women with primary breast cancer","volume":"120","author":"Satariano","year":"1994","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.jgo.2024.102184_bb0130","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1470-2045(20)30741-5","article-title":"Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG)","volume":"22","author":"Biganzoli","year":"2021","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.jgo.2024.102184_bb0135","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.2009.25.9796","article-title":"Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival","volume":"28","author":"Schonberg","year":"2010","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.jgo.2024.102184_bb0140","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/jnci\/djr257","article-title":"Incidence of breast cancer in the United States: current and future trends","volume":"103","author":"Anderson","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.jgo.2024.102184_bb0145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","article-title":"Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications","volume":"57","author":"Mangoni","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"14","key":"10.1016\/j.jgo.2024.102184_bb0150","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJMsa012528","article-title":"Understanding the treatment preferences of seriously ill patients","volume":"346","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.jgo.2024.102184_bb0155","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1200\/JCO.2009.23.1183","article-title":"American Society of Clinical Oncology guidance statement: the cost of cancer care","volume":"27","author":"Meropol","year":"2009","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jgo.2024.102184_bb0160","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1200\/JCO.2008.18.4028","article-title":"Docetaxel with cyclophosphamide is associated with an overall survival benefit compared with doxorubicin and cyclophosphamide: 7-year follow-up of US oncology research trial 9735","volume":"27","author":"Jones","year":"2009","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jgo.2024.102184_bb0165","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1186\/bcr2144","article-title":"Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials","volume":"10","author":"Loibl","year":"2008","journal-title":"Breast Cancer Res"},{"issue":"19","key":"10.1016\/j.jgo.2024.102184_bb0170","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1200\/JCO.2013.49.3676","article-title":"Risk of hospitalization according to chemotherapy regimen in early-stage breast cancer","volume":"32","author":"Barcenas","year":"2014","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jgo.2024.102184_bb0175","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.critrevonc.2011.04.001","article-title":"Adjuvant docetaxel\/cyclophosphamide in breast cancer patients over the age of 70: results of an observational study","volume":"80","author":"Freyer","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"10.1016\/j.jgo.2024.102184_bb0180","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3747\/co.19.1174","article-title":"Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-an updated analysis","volume":"19","author":"Younus","year":"2012","journal-title":"Curr Oncol"},{"issue":"20","key":"10.1016\/j.jgo.2024.102184_bb0185","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1002\/cncr.29506","article-title":"German Breast Group Investigators. A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52)","volume":"121","author":"von Minckwitz","year":"2015","journal-title":"Cancer"},{"issue":"3\u20134","key":"10.1016\/j.jgo.2024.102184_bb0190","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000127414","article-title":"Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25\/99)","volume":"73","author":"Hess","year":"2007","journal-title":"Oncology"},{"issue":"18","key":"10.1016\/j.jgo.2024.102184_bb0195","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1200\/JCO.2005.02.3028","article-title":"Use and outcomes of adjuvant chemotherapy in older women with breast cancer","volume":"24","author":"Giordano","year":"2006","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.jgo.2024.102184_bb0200","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1200\/JCO.2005.03.6053","article-title":"Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort","volume":"24","author":"Elkin","year":"2006","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.jgo.2024.102184_bb0205","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa0810266","article-title":"Adjuvant chemotherapy in older women with early-stage breast cancer","volume":"360","author":"Muss","year":"2009","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jgo.2024.102184_bb0210","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrclinonc.2009.142","article-title":"Chemotherapy: adjuvant chemotherapy in older patients with breast cancer","volume":"6","author":"Jager","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.jgo.2024.102184_bb0215","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/0959-8049(94)90526-6","article-title":"Management of breast cancer in the elderly","volume":"30A","author":"Martin","year":"1994","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.jgo.2024.102184_bb0220","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.critrevonc.2010.06.005","article-title":"Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals","volume":"79","author":"Barth\u00e9l\u00e9my","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"10.1016\/j.jgo.2024.102184_bb0225","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/cncr.20206","article-title":"The natural history of breast carcinoma in the elderly: implications for screening and treatment","volume":"100","author":"Singh","year":"2004","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.jgo.2024.102184_bb0230","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00432-022-03938-x","article-title":"For 55 breast cancer centers certified by the German Cancer society. Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers","volume":"149","author":"Ortmann","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.jgo.2024.102184_bb0235","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"ESMO guidelines committee. Electronic address: clinicalguidelines@esmo.org. Early breast cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann Oncol"},{"issue":"13","key":"10.1016\/j.jgo.2024.102184_bb0240","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.20.03399","article-title":"Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline","volume":"39","author":"Korde","year":"2021","journal-title":"J Clin Oncol"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406824004570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406824004570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T04:43:08Z","timestamp":1741149788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406824004570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1879406824004570"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2024.102184","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant taxane-based chemotherapy treatment in older patients with early breast cancer: A pooled analysis of five phase III trials from the Hellenic Oncology Research Group","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2024.102184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102184"}}